Edition:
United States

AquaBounty Technologies Inc (AQB.OQ)

AQB.OQ on NASDAQ Stock Exchange Capital Market

3.09USD
4:00pm EDT
Change (% chg)

$-0.08 (-2.52%)
Prev Close
$3.17
Open
$3.16
Day's High
$3.16
Day's Low
$3.09
Volume
4,573
Avg. Vol
31,209
52-wk High
$9.99
52-wk Low
$2.26

Chart for

About

AquaBounty Technologies, Inc. is a biotechnology company engaged in research, development and commercialization of the commercial viability of a group of proteins, antifreeze proteins (AFPs). The Company focuses on the managing aquaculture productivity. It offers AquAdvantage Salmon (AAS), which can be grown in contained,... (more)
No analyst recommendations are available for .

Overall

Beta: --
Market Cap(Mil.): $39.76
Shares Outstanding(Mil.): 12.60
Dividend: --
Yield (%): --

Financials

  AQB.OQ Industry Sector
P/E (TTM): -- 188.22 33.60
EPS (TTM): -1.05 -- --
ROI: -72.08 -0.74 13.19
ROE: -92.55 -2.80 15.00

BRIEF-Aquabounty Technologies Files Mixed Shelf Of Up To $100 Mln

* AQUABOUNTY TECHNOLOGIES INC FILES MIXED SHELF OF UP TO $100 MLN - SEC FILING Source text: [https://bit.ly/2uQtjhb] Further company coverage:

Apr 06 2018

BRIEF-AquaBounty Technologies Results For The Year Ended December

* AQUABOUNTY TECHNOLOGIES, INC. RESULTS FOR THE YEAR ENDED DECEMBER 31, 2017 Source text for Eikon: Further company coverage:

Mar 08 2018

BUZZ-AquaBounty Tech: Touches 1-yr low after stock and warrants offering

** Biotech's shares fall as much as 39.1 pct to touch a > 1-yr low of $2.96 in morning trading

Jan 12 2018

BRIEF-Aquabounty Technologies Announces $12 Mln Underwritten Public Offering

* AQUABOUNTY TECHNOLOGIES, INC. ANNOUNCES $12 MILLION UNDERWRITTEN PUBLIC OFFERING

Jan 12 2018

BRIEF-Aquabounty Technologies files for common stock offering of up to $20 million

* Files for common stock offering of up to $20 million Source text: (http://bit.ly/2hejTlV) Further company coverage:

Nov 08 2017

BRIEF-AquaBounty Technologies results for the quarter ended

* AquaBounty Technologies, Inc. results for the quarter ended September 30, 2017

Nov 02 2017

Earnings vs. Estimates

No consensus analysis data available.